ArticleThoracic cancer2022

Chemoradiation followed by adjuvant durvalumab in stage III non-small cell lung cancer: Real-world comparison of treatment outcomes to historical controls treated with chemoradiation alone.

Akram Saad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.